drugset / Trial / NCT00978146

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

NCT00978146

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the response rate of desmoid tumors to hydroxyurea. The investigators hypothesize that hydroxyurea will be a safe, non-toxic alternative to aggressive surgery or chemotherapy for this difficult to treat tumor.

Timeline

Start
2009-10
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxyurea Other / unclassified 20 mg/kg Oral

Indications